You are currently on the new version of our website. Access the old version .

Most Cited

  • Review
  • Open Access
14 Citations
36,205 Views
14 Pages

The Role of L-Carnitine in Kidney Disease and Related Metabolic Dysfunctions

  • Tim Ulinski,
  • Maria Cirulli and
  • Mohamed Ashraf Virmani

10 April 2023

Kidney disease is associated with a wide variety of metabolic abnormalities that accompany the uremic state and the state of dialysis dependence. These include altered L-carnitine homeostasis, mitochondrial dysfunctions, and abnormalities in fatty ac...

  • Review
  • Open Access
8 Citations
6,143 Views
19 Pages

Exploring the Cardiorenal Benefits of SGLT2i: A Comprehensive Review

  • Angelica Cersosimo,
  • Andrea Drera,
  • Marianna Adamo,
  • Marco Metra and
  • Enrico Vizzardi

24 October 2024

The history of sodium-glucose cotransporter 2 inhibitors (SGLT2i) is so long and started in 1835 when Petersen extracted a compound called phlorizin from apple tree bark. About fifty years later, von Mering discovered its glucosuric properties. In th...

  • Article
  • Open Access
8 Citations
3,426 Views
18 Pages

PTEN, MMP2, and NF-κB and Regulating MicroRNA-181 Aggravate Insulin Resistance and Progression of Diabetic Nephropathy: A Case-Control Study

  • Manoj Khokhar,
  • Purvi Purohit,
  • Sojit Tomo,
  • Riddhi G. Agarwal,
  • Ashita Gadwal,
  • Nitin Kumar Bajpai,
  • Gopal Krishna Bohra and
  • Ravindra Kumar Shukla

15 March 2023

Diabetic nephropathy (DN) is characterized by an increase in urinary albumin excretion, diabetic glomerular lesions, and a decline in glomerular filtration rate (GFR). We assessed the expression of phosphatase and tensin homolog (PTEN), nuclear facto...

  • Article
  • Open Access
7 Citations
4,086 Views
14 Pages

Virtual Reality Mindfulness and Personalized Exercise for Patients on Hemodialysis with Depressive Symptoms: A Feasibility Study

  • Brett T. Burrows,
  • Ashley M. Morgan,
  • Alexis C. King,
  • Rosalba Hernandez and
  • Kenneth R. Wilund

1 September 2023

Nonadherence to exercise-related trials in hemodialysis (HD) patients is a significant burden worldwide. To address this issue, we assessed the feasibility and preliminary efficacy of a combined pre-habilitative virtual-reality-based mindfulness (VRM...

  • Review
  • Open Access
6 Citations
5,504 Views
18 Pages

Apolipoprotein L1 (APOL1) nephropathy results from several podocyte dysfunctions involving morphological and motility changes, mitochondrial perturbations, inflammatory stress, and alterations in cation channel activity. I propose that this phenotype...

  • Review
  • Open Access
5 Citations
16,592 Views
15 Pages

Acute Kidney Injury Associated with Severe Leptospirosis: Fatal Re-Emerging Disease in Latin America

  • Elber Osorio-Rodríguez,
  • Dairo Rodelo-Barrios,
  • Carlos Rebolledo-Maldonado,
  • Alberto Polo-Barranco,
  • Jhonny Patiño-Patiño,
  • Mauricio Aldana-Roa,
  • Valeria Sánchez-Daza,
  • Emily Sierra-Ordoñez and
  • Alfonso Bettin-Martínez

Leptospirosis is a re-emerging zoonotic disease that has had an unprecedented impact on most health systems in the world. The spectrum of symptoms is variable and usually ranges from asymptomatic cases to severe manifestations involving multiple orga...

  • Review
  • Open Access
4 Citations
9,669 Views
23 Pages

21 August 2023

Recently, as the number of elderly dialysis patients has been increasing, complications associated with low nutritional status such as infectious disease have had a strong influence on the prognosis of dialysis patients. Nutritional disorders are cau...

  • Perspective
  • Open Access
4 Citations
4,506 Views
10 Pages

Physical activity and exercise are core components of lifestyle modification strategies for the management of chronic kidney disease (CKD). Yet, physical activity levels have consistently remained poor across all stages of CKD. Exercise interventions...

  • Review
  • Open Access
3 Citations
8,683 Views
23 Pages

IgA Nephropathy: What Is New in Treatment Options?

  • Roberto Scarpioni and
  • Teresa Valsania

3 December 2024

IgA nephropathy (IgAN), first described in 1968, is one of the most common forms of glomerulonephritis and can progress to end-stage kidney disease (ESKD) in 25 to 30 percent of patients within 20 to 25 years from the onset. It is histologically char...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Kidney Dial. - ISSN 2673-8236